BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 184 filers reported holding BLUEBIRD BIO INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,277 | -7.6% | 420 | 0.0% | 0.00% | – |
| Q2 2023 | $1,382 | +3.4% | 420 | 0.0% | 0.00% | – |
| Q1 2023 | $1,336 | -54.0% | 420 | 0.0% | 0.00% | – |
| Q4 2022 | $2,906 | -3.1% | 420 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $3,000 | +50.0% | 420 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 420 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 420 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | -50.0% | 420 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $8,000 | -38.5% | 420 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $13,000 | 0.0% | 420 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $13,000 | -27.8% | 420 | 0.0% | 0.00% | -40.0% |
| Q4 2020 | $18,000 | -21.7% | 420 | 0.0% | 0.01% | -28.6% |
| Q3 2020 | $23,000 | -8.0% | 420 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $25,000 | +31.6% | 420 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $19,000 | -47.2% | 420 | 0.0% | 0.01% | -55.6% |
| Q4 2019 | $36,000 | – | 420 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |